China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 for sale
China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 for sale
China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 for sale
China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 for sale
China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 for sale

China Supplier 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) CAS 148719-91-9 Wholesale & Bulk

Key Intermediate for Dorzolamide:
This chiral compound (CAS 130693-82-2) is a critical synthon exclusively used to manufacture dorzolamide—a prescription drug for glaucoma. Its structure features:

  • A bicyclic thienothiopyran core with two sulfone groups (*7,7-dioxide*).

  • ketone at C4 and methyl group at C6.

  • (6S)-stereochemistry: Essential for biological activity.

Chemical Role:
The C4 ketone undergoes stereoselective reductive amination with ethylamine, directly forming dorzolamide’s active pharmacophore. No other significant applications exist. Handled as a solid under controlled conditions to preserve chirality.


The compound 4H-Thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, 7,7-dioxide, (6S) is a key chiral intermediate in the synthesis of dorzolamide (a carbonic anhydrase inhibitor used to treat glaucoma). Here's a concise breakdown:

Chemical Structure & Features

Core Skeleton:

    • Bicyclic system: Thieno[2,3-b]thiopyran (fusion of thiophene + thiopyran rings).

    • 7,7-Dioxide: Both sulfur atoms oxidized to sulfones (critical for bioactivity).

    • 5,6-Dihydro: Partial saturation at the 5-6 bond.

    • 4-one: Ketone at position 4.

    • 6-Methyl: Methyl group at C6.

    • (6S): Chiral center with S-configuration at C6 (essential for drug efficacy).

      Systematic Name:

      *(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide*

    • CAS Registry: 130693-82-2 (specific to the (6S)-enantiomer).

Primary Chemical Use

  • Synthesis of Dorzolamide:
    This compound is the immediate precursor to dorzolamide’s core structure. In the final steps:

  • *(4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide*.

  • The ketone (C4=O) undergoes reductive amination with ethylamine.

    Introduces the ethylamino group (–NHCH₂CH₃) at C4.

    Yields dorzolamide’s active pharmacophore:

Key Properties & Handling

  • Chiral Purity: The (6S)-configuration must be preserved to match dorzolamide’s stereochemistry.

  • Reactivity:

  • Ketone at C4 is highly reactive for nucleophilic addition (e.g., amines).

    Sulfone groups enhance electrophilicity and binding to carbonic anhydrase.

  • Stability: Sensitive to epimerization at C6; requires controlled conditions (low temperature, inert atmosphere).

  • Handling: Typically handled as a solid (crystalline) under anhydrous conditions.

Why It Matters

  • Pharmaceutical Role: Enables stereoselective production of dorzolamide, ensuring clinical efficacy.

  • Synthetic Challenge: Asymmetric synthesis/purification of (6S)-isomer is critical for regulatory compliance.

  • Patent Significance: Protected under dorzolamide manufacturing patents (e.g., Merck & Co.).

For reference:
Final Step:

This intermediate is not biologically active itself but is indispensable for constructing the therapeutic molecule.


Fortunachem Chemicals
Get In Touch With Fortunachem

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help

Related Active Pharmaceutical Ingredient API Fine Chemicals
MORE
Latest News & Blogs

Keeping you up-to-date with all the latest information, news, and events about Fortunachem!